Sidsel Støy

Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial

Vishal Patel, Sunjae Lee, Mark McPhail et al. · Journal of Hepatology · 2021 · 198 citations · Full text

Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial

Simon Mark Dahl Baunwall, Sara Ellegaard Andreasen, Mette Mejlby Hansen et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 112 citations

Dysbiosis, Antimicrobial Susceptibility, Placebo-controlled Trial +7

Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study

Thomas Damgaard Sandahl, Henning Grønbæk, Holger Jon Møller et al. · The American Journal of Gastroenterology · 2014 · 96 citations

Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease

Anders Dige, Sidsel Støy, Tue Kruse Rasmussen et al. · Journal of Crohn s and Colitis · 2012 · 60 citations

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients

Thomas Damgaard Sandahl, Sidsel Støy, Tea Lund Laursen et al. · PLoS ONE · 2017 · 40 citations · Full text